Novel technology, using single-color digital PCR, could enable the detection of cancerous DNA in circulating blood.
Researchers have demonstrated the promise of quantitative whole genome sequencing of circulating tumor cells in enabling personalized combination therapy of metastatic cancer.
In this article, the authors provide an up-to-date review of all reported genomic aberrations in the eight most common pediatric solid tumors with whole-exome sequencing or whole-genome sequencing data.
Targeted sequencing focused on cancer-related genes provides comprehensive assessment of tumor mutational burden, with results comparable to whole-exome sequencing.
NGS-guided assessment of interactions between tumors and the immune system leads to new discoveries…
Researchers have unearthed molecular changes along the digestive tract that could aid the development of targeted therapies.
Researchers have developed an innovative technique to detect tumor DNA in blood with a greater degree of sensitivity and precision.
In this article the authors discuss how extensive biobanking for each individual patient with subsequent genome sequencing can open novel horizons for precision medicine in breast cancer.
In this commentary, the author discusses how the companion paradigm is playing out in immuno-oncology and why we are likely to achieve much more in the next 10 years than we have in the previous two decades.
New results suggest non-invasive liquid biopsy for NSCLC is an effective alternative to current gold standard tests.